MCCLENNEN PETER A 4
4 · Teladoc Health, Inc. · Filed Jun 19, 2019
Insider Transaction Report
Form 4
MCCLENNEN PETER A
President
Transactions
- Sale
Common Stock
2019-06-17$60.01/sh−1,730$103,817→ 16,299 total - Sale
Common Stock
2019-06-17$60.02/sh−6,629$397,873→ 9,670 total - Exercise/Conversion
Common Stock
2019-06-17$32.50/sh+1,730$56,225→ 11,400 total - Exercise/Conversion
Common Stock
2019-06-17$38.55/sh+6,629$255,548→ 18,029 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-06-17−1,730→ 143,276 totalExercise: $32.50Exp: 2027-11-03→ Common Stock (1,730 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2019-06-17−6,629→ 82,910 totalExercise: $38.55Exp: 2028-03-01→ Common Stock (6,629 underlying)
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019.
- [F2]Represents the weighted average price of transactions ranging from $60.00 to $60.03. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average price of transactions ranging from $60.00 to $60.09. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]The option vests as to 25% of the shares on November 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
- [F5]The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.